Logo image of CRON.CA

CRONOS GROUP INC (CRON.CA) Stock Overview

TSX:CRON - CA22717L1013 - Common Stock

3.56 CAD
-0.01 (-0.28%)
Last: 8/29/2025, 7:00:00 PM

CRON.CA Key Statistics, Chart & Performance

Key Statistics
52 Week High3.81
52 Week Low2.27
Market Cap1.36B
Shares383.04M
Float198.04M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.07
PE50.86
Fwd PE36.26
Earnings (Next)11-10 2025-11-10
IPO05-07 2014-05-07
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


CRON.CA short term performance overview.The bars show the price performance of CRON.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

CRON.CA long term performance overview.The bars show the price performance of CRON.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 20

The current stock price of CRON.CA is 3.56 CAD. In the past month the price increased by 29.93%. In the past year, price increased by 17.49%.

CRONOS GROUP INC / CRON Daily stock chart

CRON.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.95 3.76B
TLRY.CA TILRAY BRANDS INC N/A 2.08B
DHT-UN.CA DRI HEALTHCARE TRUST 6.59 784.17M
WEED.CA CANOPY GROWTH CORP N/A 657.29M
GUD.CA KNIGHT THERAPEUTICS INC N/A 647.73M
TSND.CA TERRASCEND CORP N/A 580.48M
DHT-U.CA DRI HEALTHCARE TRUST 4.7 559.49M
ACB.CA AURORA CANNABIS INC N/A 416.25M
CPH.CA CIPHER PHARMACEUTICALS INC 25.29 404.46M
HITI.CA HIGH TIDE INC N/A 401.13M
OGI.CA ORGANIGRAM GLOBAL INC N/A 317.02M
NGEN.CA NERVGEN PHARMA CORP N/A 264.54M

About CRON.CA

Company Profile

CRON logo image Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The firm distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.

Company Info

CRONOS GROUP INC

4491 Concession Rd 12

TORONTO ONTARIO M5V2G9 CA

CEO: Kurt T. Schmidt

Employees: 626

CRON Company Website

CRON Investor Relations

Phone: 14165040004

CRONOS GROUP INC / CRON.CA FAQ

What is the stock price of CRONOS GROUP INC today?

The current stock price of CRON.CA is 3.56 CAD. The price decreased by -0.28% in the last trading session.


What is the ticker symbol for CRONOS GROUP INC stock?

The exchange symbol of CRONOS GROUP INC is CRON and it is listed on the Toronto Stock Exchange exchange.


On which exchange is CRON.CA stock listed?

CRON.CA stock is listed on the Toronto Stock Exchange exchange.


What is the price forecast or stock price prediction for CRONOS GROUP INC stock?

8 analysts have analysed CRON.CA and the average price target is 2.4 CAD. This implies a price decrease of -32.67% is expected in the next year compared to the current price of 3.56. Check the CRONOS GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CRONOS GROUP INC worth?

CRONOS GROUP INC (CRON.CA) has a market capitalization of 1.36B CAD. This makes CRON.CA a Small Cap stock.


How many employees does CRONOS GROUP INC have?

CRONOS GROUP INC (CRON.CA) currently has 626 employees.


What are the support and resistance levels for CRONOS GROUP INC (CRON.CA) stock?

CRONOS GROUP INC (CRON.CA) has a support level at 3.28 and a resistance level at 3.62. Check the full technical report for a detailed analysis of CRON.CA support and resistance levels.


Is CRONOS GROUP INC (CRON.CA) expected to grow?

The Revenue of CRONOS GROUP INC (CRON.CA) is expected to grow by 12.95% in the next year. Check the estimates tab for more information on the CRON.CA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CRONOS GROUP INC (CRON.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CRONOS GROUP INC (CRON.CA) stock pay dividends?

CRON.CA does not pay a dividend.


When does CRONOS GROUP INC (CRON.CA) report earnings?

CRONOS GROUP INC (CRON.CA) will report earnings on 2025-11-10.


What is the Price/Earnings (PE) ratio of CRONOS GROUP INC (CRON.CA)?

The PE ratio for CRONOS GROUP INC (CRON.CA) is 50.86. This is based on the reported non-GAAP earnings per share of 0.07 and the current share price of 3.56 CAD. Check the full fundamental report for a full analysis of the valuation metrics for CRON.CA.


CRON.CA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to CRON.CA. When comparing the yearly performance of all stocks, CRON.CA is one of the better performing stocks in the market, outperforming 74.68% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CRON.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CRON.CA. While CRON.CA has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CRON.CA Financial Highlights

Over the last trailing twelve months CRON.CA reported a non-GAAP Earnings per Share(EPS) of 0.07. The EPS increased by 162.5% compared to the year before.


Industry RankSector Rank
PM (TTM) 14.19%
ROA 1.57%
ROE 1.71%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-400%
Sales Q2Q%20.51%
EPS 1Y (TTM)162.5%
Revenue 1Y (TTM)28.01%

CRON.CA Forecast & Estimates

8 analysts have analysed CRON.CA and the average price target is 2.4 CAD. This implies a price decrease of -32.67% is expected in the next year compared to the current price of 3.56.

For the next year, analysts expect an EPS growth of -115.3% and a revenue growth 12.95% for CRON.CA


Analysts
Analysts80
Price Target2.4 (-32.58%)
EPS Next Y-115.3%
Revenue Next Year12.95%

CRON.CA Ownership

Ownership
Inst Owners13.12%
Ins Owners6.2%
Short Float %N/A
Short RatioN/A